<DOC>
	<DOC>NCT01426958</DOC>
	<brief_summary>To study the effect of the P-glycoprotein inhibitor ritonavir on the pharmacokinetics (PK) of afatinib depending on the timepoint of ritonavir administration</brief_summary>
	<brief_title>Investigation of Ritonavir Effects on Afatinib Exposure in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<criteria>Inclusion criteria: 1. healthy male subjects Exclusion criteria: 1. any relevant deviation from healthy conditions</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>